Euronext announces volumes for June 2018 CONTACT - Media:

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
184
Euronext announces volumes for June 2018
CONTACT - Media:   CONTACT - Investor Relations:
Amsterdam +31.20.721.4488 Brussels +32.2.620.15.50 +33.1.70.48.24.27    
Dublin Lisbon +353.1.617.4266 +351.210.600.614 Paris +33.1.70.48.24.45      
           
           
           

EURONEXT ANNOUNCES VOLUMES FOR JUNE 2018

Amsterdam, Brussels, Lisbon, London, Dublin and Paris - 5 July 2018 - Euronext, the leading pan-European exchange in the Eurozone, today announced trading volumes for June 2018.

Cash trading In June 2018, the average daily transaction value on the Euronext cash order book stood at €8,822.3 million, up +2.1% compared to June 2017 and up +3.5% from the previous month. In the first six months of 2018, the average daily transaction value on the Euronext cash order book was €8,566.2 million, up +8.9% compared to last year. The average daily transaction value on the ETF order book [1] was €248 million, up +8.0% compared to June 2017 and down -9.3% from the previous month. At the end of June 2018, 1,073 ETFS were listed on Euronext compared to 1,048 at the end of December 2017.

Derivatives trading In June 2018, the overall average daily volume on derivatives reached 582,375 contracts, down -24.3% compared to June 2017 and down -9.7% compared to the previous month. In detail:

  • the average daily volume on equity index derivatives reached 243,353 contracts, down -1.7% compared to June 2017 and up +9.5% from the previous month,
  • the average daily volume on individual equity derivatives reached 276,746 contracts, down -40.4% compared to June 2017 and down -23.0% from the previous month,
  • the average daily volume on commodities derivatives reached 62,276 contracts, up +9.1% compared to June 2017 and down -1.9% from the previous month.

June 2017 figures included a total of 5.6 million equity and index option contracts, resulting from the planned non-recurring migration of open interest from TOM to Euronext, which took place from the end of May 2017 to the end of June 2017. At the end of June 2018, the overall average daily volume on Euronext derivatives stood at 598,111 contracts (+4.4% compared to the end of June 2017) and open interest was up at 17,918,034 contracts (+15.5% compared to the end of June 2017).

FX spot trading In June 2018, the average daily volume on the spot foreign exchange market of FastMatch, operating as a Euronext company since August 2017, stood at $22,240 million, up +13.0% compared to June 2017 and down -1.5% from the previous month.

Listings In June 2018, Euronext welcomed seven listings, including Adyen (the largest tech unicorn IPO in Europe in the last five years [2] ), Unibail-Rodamco-Westfield, Cogelec and 2CRSI on Euronext main market, Enensys Technologies and Kalray on Euronext Growth and Yew Grove Reit on ESM in Dublin. Altogether, they raised €1,067 million. In addition, €58.7 billion was raised on Euronext in bonds, of which €2.3 billion was in five green bonds; and €4.1 billion was raised in follow-on equity.

CONTACTS

Media  Aïchata Tandjigora                                     +33 1 70 48 24 43; mediateam@euronext.com

Analysts & investors Aurélie Cohen / Clément Kubiak:           +33 1 70 48 24 27; ir@euronext.com

About Euronext Euronext is the leading pan-European exchange in the Eurozone with nearly 1,300 listed issuers worth close to €3.9 trillion in market capitalisation as of end June 2018, an unmatched blue chip franchise consisting of 24 issuers in the Morningstar® Eurozone 50 Index SM and a strong diverse domestic and international client base.  Euronext operates regulated and transparent equity and derivatives markets. Its total product offering includes Equities, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, Euronext also operates Euronext Growth TM (formerly known as Alternext) and Euronext Access TM (formerly known as the Free Market). For the latest news, find us on Twitter ( twitter.com/euronext ) and LinkedIn ( linkedin.com/euronext ).

Disclaimer This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided "as is" without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication June be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext's subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext. This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use . © 2018, Euronext N.V. - All rights reserved.

The Euronext Group processes your personal data in order to provide you with information about Euronext (the "Purpose"). With regard to the processing of these personal data, Euronext will comply with its obligations under the Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (General Data Protection Regulation, "GDPR"), and any applicable national laws, rules and regulations implementing the GDPR. In accordance with the applicable legislation you have a right to access your personal data and a right to the rectification, erasure, restriction of processing, data portability or to object to the processing of your personal data. You may also submit a complaint to the competent data privacy authority. For any request regarding the processing of your data, please use our data subject request form or email our Data Protection Officer at dpo@euronext.com . Your personal data will be retained as long as necessary for the Purpose and will be accessible only to the extent necessary for this specific Purpose.

Cash markets activity

 
  Jun-18 May-18   Jun-17   Q2 2018 Q2 2017   YTD 2018 YTD 2017  
Nb trading days 21 22   22   63 62   126 127  
 
NUMBER OF TRANSACTIONS (Buy and sells) (reported trades included)
  Jun-18 May-18 Change % MOM Jun-17 Change % YOY Q2 2018 Q2 2017 Change % YTD 2018 YTD 2017 Change % YTD
Total Cash Market 1 37 989 506 39 360 656 -3,5% 45 612 486 -16,7% 112 286 632 131 850 012 -14,8% 242 114 604 246 995 110 -2,0%
ADV Cash Market 1 1 809 024 1 789 121 1,1% 2 073 295 -12,7% 1 782 327 2 126 613 -16,2% 1 921 544 1 944 843 -1,2%
 
 
TRANSACTION VALUE ( € million - Single counted)
Eur million Jun-18 May-18 Change % MOM Jun-17 Change % YOY Q2 2018 Q2 2017 Change % YTD 2018 YTD 2017 Change % YTD
Total Cash Market 1 185 268,8 187 561,9 -1,2% 190 065,4 -2,5% 530 356 535 554 -1,0% 1 079 335,6 998 775,9 8,1%
ADV Cash Market 1 8 822,3 8 525,5 3,5% 8 639,3 2,1% 8 418 8 638 -2,5% 8 566,2 7 864,4 8,9%
 
LISTINGS
Number of Issuers on Equities Jun-18 May-18 Change % MOM Jun-17 Change % YOY       Dec 2017 Change %  
 
EURONEXT 2 1 291 1 286 0,4% 1 328 -2,8%       1306 -1,1%  
SMEs 730 725 0,7% 764 -4,5%       747 -2,3%  
Number of Listed Securities
Bonds 37 774 37 491 0,8% 35 634 6,0%       37 085 1,9%  
ETFs 1 071 1 060 1,0% 1 043 2,7%       1 048 2,2%  
Funds 5 357 5 374 -0,3% 5 916 -9,4%       5 662 -5,4%  
 
EURONEXT
CAPITAL RAISED on Equities on Primary and Secondary Market
(mln of €) Jun-18 May-18 Change % MOM Jun-17 Change % YOY Q2 2018 Q2 2017 Change % YTD 2018 YTD 2017 Change % YTD
Nb New Listings 7 2   5   10 9   17 15  
Money Raised New Listings  incl over allotment 1 067 61 1659,3% 1 428 -25,3% 1 141 2 561 -55,4% 2 062 2 751 -25,0%
of which Money Raised New Listings 1 067 57 1783,0% 1 411 -24,4% 1 136 2 436 -53,4% 2 034 2 619 -22,3%
Follow-ons on Equities 4 144 3 022 37,1% 10 599 -60,9% 10 645 23 894 -55,4% 19 953 35 532 -43,8%
Bonds 58 704 44 373 32,3% 168 413 -65,1% 8 203 11 105 -26,1% 415 227 482 637 -14,0%
Total Money Raised 4 63 915 47 455 34,7% 180 441 -64,6% 19 989 37 561 -46,8% 437 243 520 920 -16,1%
 
 
of which SMEs
CAPITAL RAISED on Equities on Primary and Secondary Market
(mln of €) Jun-18 May-18 Change % MOM Jun-17 Change % YOY Q2 2018 Q2 2017 Change % YTD 2018 YTD 2017 Change % YTD
Nb New Listings 5 2   4   8 5   13 9  
Money Raised New Listings  incl over allotment 218 61 259,2% 262 -16,8% 292 320 -8,8% 512 510 0,4%
of which Money Raised New Listings 218 57 284,5% 255 -14,5% 287 306 -6,2% 507 488 3,9%
Follow-ons on Equities 788 354 122,6% 444 77,5% 1 571 1 127 39,4% 3 151 3 708 -15,0%
Bonds 64 31 108,9% 518 -87,6% 145 750 -80,7% 185 769 -75,9%
Total Money Raised 4 1 070 445 140,3% 1 224 -12,6% 2 008 2 197 -8,6% 3 848 4 986 -22,8%
1 Shares, warrants, ETFs, bonds 2 Euronext, Euronext Growth and Euronext Access 4 including New Listings incl over allotment, Follow-ons on Equities, Corporate Bonds on Euronext Listed Issuers

Derivatives markets activity

  Jun-18 May-18   Jun-17   Q2 2018 Q2 2017   YTD 2018 YTD 2017  
Nb trading days 21 22   22   63 62   126 127  
                       
Volume (in lots)                    
  Jun-18 May-18 Change % MOM Jun-17 Change %  YOY Q2 2018 Q2 2017 Change % Jan 2018 till Jun 2018 Jan 2017 till Jun 2017 Change % YTD
Equity 10 922 076 12 792 159 -14,6% 15 666 046 -30,3% 34 003 558 35 949 902 -5,4% 68 329 778 66 177 480 3,3%
of which AtomX 86 651 169 797       323087 130521   582 009 285 981  
                       
Index 5 110 412 4 887 427 4,6% 5 444 749 -6,1% 14 191 432 15 246 269 -6,9% 29 255 421 29 530 428 -0,9%
of which AtomX 33 981 23 600       97 831 25 576   200 307 66 557  
Futures 3 556 146 3 346 926 6,3% 4 103 816 -13,3% 9 743 850 11 697 736 -16,7% 20 088 270 22 617 817 -11,2%
of which AtomX 25 201 23 600       89 051 25 576   191 527 58 857  
Options 1 554 266 1 540 501 0,9% 1 340 933 15,9% 4 447 582 3 548 533 25,3% 9 167 151 6 912 611 32,6%
of which AtomX 8 780 0       8 780     8 780 7 700  
                       
Individual Equity 5 811 664 7 904 732 -26,5% 10 221 297 -43,1% 19 812 126 20 703 633 -4,3% 39 074 357 36 647 052 6,6%
of which AtomX 52 670 146 197       225 256 104 945   381 702 219 424  
Futures 29 516 88 471 -66,6% 58 529 -49,6% 131 927 189 147 -30,3% 149 849 223 818 -33,0%
of which AtomX 8 900 41 771       52 671 12 000   56 171 20 000  
Options 5 782 148 7 816 261 -26,0% 10 162 768 -43,1% 19 680 199 20 514 486 -4,1% 38 924 508 36 423 234 6,9%
of which AtomX 43 770 104 426       172 585 92 945   325 531 199 424  
                       
Commodity 1 307 789 1 397 020 -6,4% 1 255 540 4,2% 3 895 678 3 123 075 24,7% 7 032 231 6 544 264 7,5%
Futures 1 168 918 1 258 747 -7,1% 1 124 808 3,9% 3 568 100 2 856 493 24,9% 6 505 850 6 044 691 7,6%
Options 138 871 138 273 0,4% 130 732 6,2% 327 578 266 582 22,9% 526 381 499 573 5,4%
                       
Other 0 0   0   0 0   0 18 399  
Futures 0 0   0   0 0   0 0  
Options 0 0   0   0 0   0 18 399  
                       
Total Futures 4 754 580 4 694 144 1,3% 5 287 153 -10,1% 13 443 877 14 743 376 -8,8% 26 743 969 28 886 326 -7,4%
Total Options 7 475 285 9 495 035 -21,3% 11 634 433 -35,7% 24 455 359 24 329 601 0,5% 48 618 040 43 853 817 10,9%
                       
Total Euronext 12 229 865 14 189 179 -13,8% 16 921 586 -27,7% 37 899 236 39 072 977 -3,0% 75 362 009 72 740 143 3,6%
ADV (in lots)                    
  Jun-18 May-18 Change % MOM Jun-17 Change %  YOY Q2 2018 Q2 2017 Change % Jan 2018 till Jun 2018 Jan 2017 till Jun 2017 Change % YTD
Equity 520 099 581 462 -10,6% 712 093 -27,0% 539 739 579 837 -6,9% 542 300 521 083 4,1%
of which AtomX 4 126 7 718       5 128 2 105   4 619    
                       
Index 243 353 222 156 9,5% 247 489 -1,7% 225 261 245 908 -8,4% 232 186 232 523 -0,1%
of which AtomX 1 618 1 073       1 553 413   1 590    
Futures 169 340 152 133 11,3% 186 537 -9,2% 154 664 188 673 -18,0% 159 431 178 093 -10,5%
of which AtomX 1 200 1 073       1 414 413   1 520    
Options 74 013 70 023 5,7% 60 952 21,4% 70 597 57 234 23,3% 72 755 54 430 33,7%
of which AtomX 418 0       139 0   70    
                       
Individual Equity 276 746 359 306 -23,0% 464 604 -40,4% 314 478 333 930 -5,8% 310 114 288 559 7,5%
of which AtomX 2 508 6 645       3 575 1 693   3 029    
Futures 1 406 4 021 -65,0% 2 660 -47,2% 2 094 3 051 -31,4% 1 189 1 762 -32,5%
of which AtomX 424 1 899       836 194   446    
Options 275 340 355 285 -22,5% 461 944 -40,4% 312 384 330 879 -5,6% 308 925 286 797 7,7%
of which AtomX 2 084 4 747       2 739 1 499   2 584    
                       
Commodity 62 276 63 501 -1,9% 57 070 9,1% 61 836 50 372 22,8% 55 811 51 530 8,3%
Futures 55 663 57 216 -2,7% 51 128 8,9% 56 637 46 072 22,9% 51 634 47 596 8,5%
Options 6 613 6 285 5,2% 5 942 11,3% 5 200 4 300 20,9% 4 178 3 934 6,2%
                       
Other 0 0   0   0 0   0 145  
Futures 0 0   0   0 0   0 0  
Options 0 0   0   0 0   0 145  
                       
Total Futures 226 409 213 370 6,1% 240 325 -5,8% 213 395 237 796 -10,3% 212 254 227 451 -6,7%
Total Options 355 966 431 593 -17,5% 528 838 -32,7% 388 180 392 413 -1,1% 385 857 345 306 11,7%
                       
Total Euronext 582 375 644 963 -9,7% 769 163 -24,3% 601 575 630 209 -4,5% 598 111 572 757 4,4%
Open Interest        
  Jun-18 May-18 Change % MOM Jun-17 Change %  YOY
Equity 17 176 034 19 737 645 -13,0% 14 814 255 15,9%
           
Index 1 501 496 1 661 789 -9,6% 1 520 050 -1,2%
Futures 617 666 634 236 -2,6% 620 636 -0,5%
Options 883 830 1 027 553 -14,0% 899 414 -1,7%
           
Individual Equity 15 674 538 18 075 856 -13,3% 13 294 205 17,9%
Futures 21 237 26 059 -18,5% 21 632 -1,8%
Options 15 653 301 18 049 797 -13,3% 13 272 573 17,9%
           
Commodity 742 000 664 763 11,6% 703 386 5,5%
Futures 463 772 446 325 3,9% 443 650 4,5%
Options 278 228 218 438 27,4% 259 736 7,1%
           
           
Other 0 0   0  
Futures 0 0   0  
Options 0 0   0  
           
           
Total Futures 1 102 675 1 106 620 -0,4% 1 085 918 1,5%
Total Options 16 815 359 19 295 788 -12,9% 14 431 723 16,5%
           
Total Euronext 17 918 034 20 402 408 -12,2% 15 517 641 15,5%

Spot FX Trading

  Jun-18 May-18   Jun-17   Q2 2018 Q2 2017   YTD 2018 YTD 2017  
Nb trading days 21 23   22   64 65   129 129  
                       
Fastmatch  Volume (in USD millions, single counted)              
  Jun-18 May-18 Change % MOM Jun-17 Change % YOY Q2 2018 Q2 2017 Change % YTD 2018 YTD 2017 Change % YTD
Total FastMatch Market 467 039 519 153 -10,0% 432 992 7,9% 1 392 878 1 332 091 4,6% 2 685 181 2 462 397 9,0%
ADV FastMatch Market 22 240 22 572 -1,5% 19 681 13,0% 21 764 20 494 6,2% 20 815 19 088 9,0%

[1] From January 2018, volumes on ETFs are only measured on order book activity due to low revenue-impact of off-book activity. Based on the previous presentation, activity is €414 million, down -15.7% compared to June 2017

[2] Based on market capitalisation at opening.

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 158

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 119

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 183

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 365

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 139

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading

Top 5 Most Recently Viewed Articles

BlueLinx Expands Its Reach with New Portland Distribution Hub

Updated Category News Views 147

BlueLinx Unveils New Distribution Center in Portland BlueLinx Holdings Inc. (NYSE: BXC) has officially opened a greenfield distribution center in Portland, enhancing its operational footprint in the Pacific Northwest. This facility is a significant addition to the company’s distribution capabilities, as it strategically positions BlueLinx to serve the growing demands of...

Continue Reading
IBA Partners with China Gold to Advance X-ray Technological Growth

Updated Category News Views 255

Strategic Partnership for Industry Advancement In a significant move for the irradiation processing industry, IBA (Ion Beam Applications S.A., EURONEXT) has joined forces with China Gold Irradiation (CGI), the premier irradiation service provider in China. This collaboration is set to elevate the standards of irradiation services by incorporating advanced X-ray...

Continue Reading
Amerant Bank and Partners Generate Support for Local Charity

Updated Category News Views 189

Generous Collaboration: Amerant Bank's Community Impact In a heartwarming display of community spirit, Amerant Bank has partnered with Sedano’s Supermarkets and Fresco y Más to make a significant difference in the lives of underserved children and families. The culmination of their efforts was marked by a grand check presentation to Centro Mater, a renowned...

Continue Reading
Mediar Therapeutics Advances Phase 2 Trial for Rare Lung Disease

Updated Category News Views 123

Mediar Therapeutics Initiates Phase 2 WISPer Trial Mediar Therapeutics, Inc., a pioneering clinical-stage biotechnology company, has reached a major milestone by dosing the first patient in its Phase 2 WISPer clinical trial. This trial focuses on evaluating MTX-463, a first-in-class therapy designed to combat idiopathic pulmonary fibrosis (IPF). The primary goal of this...

Continue Reading
Chime Biologics and Waterstone Unite for ADC Innovation

Updated Category News Views 242

Chime Biologics and Waterstone Forge a New Path in ADC Development Chime Biologics and Waterstone Pharmaceuticals have officially announced a strategic partnership designed to enhance the capabilities and efficiencies within the Antibody-Drug Conjugate (ADC) industry. By combining their expertise, both companies aim to provide integrated services that boost the...

Continue Reading